Pluristem Therapeutics Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K Current Report covers events occurring on June 21, 2022, and June 23, 2022, regarding Pluristem Therapeutics Inc. (PSTI). The filing details the outcomes of the Company's 2022 Annual Meeting of Stockholders held on June 21, 2022, specifically focusing on the election of directors and the ratification of the independent auditor.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current report on corporate governance events and does not contain financial performance data.
Material Changes
Significant changes to the Board of Directors occurred following the Annual Meeting:
- Departures: Mark Germain, Moria Kwiat, and Doron Shorrer were not re-elected as directors and vacated their seats effective June 21, 2022. Consequently, they also vacated their roles on the Nominating, Compensation, and Audit Committees.
- Appointments: On June 23, 2022, the Board appointed new committee members to fill the vacancies:
- Audit Committee: Ms. Varda Shalev appointed as a member; Mr. Doron Birger appointed as Chairman.
- Compensation Committee: Ms. Maital Shemesh-Rasmussen and Ms. Shalev appointed as members; Ms. Shemesh-Rasmussen appointed as Chairperson.
- Nominating Committee: Mr. Rami Levi and Ms. Shemesh-Rasmussen appointed as members; Mr. Levi appointed as Chairman.
Guidance, Outlook, and Voting Results
The filing reports the final voting results for the 2022 Annual Meeting:
- Proposal 1 (Election of Directors):
- Not Re-elected: Mark Germain (4,599,082 Against), Moria Kwiat (4,162,124 Against), and Doron Shorrer (4,466,393 Against).
- Re-elected: Zami Aberman, Doron Birger, Rami Levi, Varda Shalev, Maital Shemesh-Rasmussen, and Yaky Yanay received majority "For" votes.
- Proposal 2 (Ratification of Auditor): Stockholders ratified the selection of Kesselman & Kesselman (a member firm of PricewaterhouseCoopers International Limited) as the independent registered public accounting firm for the fiscal year ending June 30, 2022, with 13,375,832 votes For and 88,651 votes Against.
The filing contains no management commentary on future guidance, risks, contingencies, or unusual items.
Investor Verification Checklist
- Verify the specific reasons for the significant "Against" votes cast for directors Mark Germain, Moria Kwiat, and Doron Shorrer.
- Confirm the new composition of the Audit, Compensation, and Nominating Committees as of June 23, 2022.
- Review the Company's subsequent filings for any impact of the board changes on strategic direction or executive compensation policies.